Literature DB >> 11839522

Bacterial toxins as tools for mucosal vaccination.

Randall J Mrsny1, Ann L Daugherty, Marian L McKee, David J FitzGerald.   

Abstract

Several studies have demonstrated that the biological properties of secreted bacterial toxins could be harnessed for the induction of mucosal and systemic immunity following application at epithelial surfaces. Although the properties and potential application of several of these toxins will be discussed in this review, special focus will be placed on Pseudomonas aeruginosa exotoxin A (PE). A non-toxic form of PE (ntPE) into which antigenic epitopes can be integrated appears to be a particularly promising vaccination tool, which is able to cross the polarized epithelia of the gastrointestinal, respiratory and reproductive tracts and selectively target macrophages and dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839522     DOI: 10.1016/s1359-6446(01)02139-0

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  7 in total

1.  Introduction for the special issue on recent advances in drug delivery across tissue barriers.

Authors:  Randall J Mrsny; David J Brayden
Journal:  Tissue Barriers       Date:  2016-06-07

2.  Evolving importance of biologics and novel delivery systems in the face of microbial resistance.

Authors:  Terry L Bowersock
Journal:  AAPS PharmSci       Date:  2002

3.  Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea Pigs.

Authors:  Sreerupa Challa; Steven M Szczepanek; Debra Rood; Roger W Barrette; Lawrence K Silbart
Journal:  Adv Virol       Date:  2011-09-22

4.  Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells.

Authors:  Jennifer C Hsieh; Doris M Tham; Weijun Feng; Fan Huang; Selamawit Embaie; Keyi Liu; Deborah Dean; Ralf Hertle; David J Fitzgerald; Randall J Mrsny
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.609

5.  Rational Design and Evaluation of an Artificial Escherichia coli K1 Protein Vaccine Candidate Based on the Structure of OmpA.

Authors:  Hao Gu; Yaling Liao; Jin Zhang; Ying Wang; Zhiyong Liu; Ping Cheng; Xingyong Wang; Quanming Zou; Jiang Gu
Journal:  Front Cell Infect Microbiol       Date:  2018-05-23       Impact factor: 5.293

6.  Cholix protein domain I functions as a carrier element for efficient apical to basal epithelial transcytosis.

Authors:  Alistair Taverner; Julia MacKay; Floriane Laurent; Tom Hunter; Keyi Liu; Khushdeep Mangat; Lisa Song; Elbert Seto; Sally Postlethwaite; Aatif Alam; Apurva Chandalia; Minji Seung; Mazi Saberi; Weijun Feng; Randall J Mrsny
Journal:  Tissue Barriers       Date:  2020-01-13

7.  Crystal Structure of Exotoxin A from Aeromonas Pathogenic Species.

Authors:  Geoffrey Masuyer
Journal:  Toxins (Basel)       Date:  2020-06-15       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.